about
High prevalence of sexually transmitted diseases among men who have sex with men in Jiangsu Province, ChinaThe effect of case rate and coinfection rate on the positive predictive value of a registry data-matching algorithm.Matching AIDS and tuberculosis registry data to identify AIDS/tuberculosis comorbidity cases in California.Monitoring outcomes for newly diagnosed and prevalent HIV cases using a care continuum created with New York city surveillance data.Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature.The Association Between Neighborhood Poverty and HIV Diagnoses Among Males and Females in New York City, 2010-2011.Continuum of Care Among People Living with Perinatally Acquired HIV Infection in New York City, 2014.Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003.Racial and socioeconomic disparities in viral suppression among persons living with HIV in New York City.Hospitalization Rates Among People With HIV/AIDS in New York City, 2013.Brief Report: HIV Prevalence and the Prevalence of Unsuppressed HIV in New York City, 2010-2014.Using the Revised Centers for Disease Control and Prevention Staging System to Classify Persons Living With Human Immunodeficiency Virus in New York City, 2011-2015.New York City Achieves the UNAIDS 90-90-90 Targets for HIV-Infected Whites but Not Latinos/Hispanics and Blacks.Estimated HIV Incidence in the United States, 2003-2010.Persistent Racial Disparities in HIV Infection in the USA: HIV Prevalence Matters.Comparison of indicators measuring the proportion of human immunodeficiency virus-infected persons with a suppressed viral load.A run-in period is needed in randomized controlled trials of directly observed antiretroviral therapy for HIV infection.Proportions of patients with HIV retained in care and virally suppressed in New York City and the United States: higher than we thought.The high proportion of late HIV diagnoses in the USA is likely to stay: findings from a mathematical model.To weight or not to weight in time-location sampling: why not do both?Limitations of indicators of HIV case finding.Recent decline in the incidence of human immunodeficiency virus infection among California men who have sex with men.Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men.The effect of venue sampling on estimates of HIV prevalence and sexual risk behaviors in men who have sex with men.HIV prevalence and sexual risk behaviors among men who have sex with men: results from a statewide population-based survey in California.Evolution of tuberculosis/HIV co-infection in California during the HAART Era, 1996-2007.Persons living with diagnosed HIV in New York City: over 50% over 50 years old.Should we report the proportion of late HIV diagnoses?Linkage to Care After HIV Diagnosis in New York City: Better Than We Thought.Retention in care and viral suppression among persons living with HIV/AIDS in New York City, 2006-2010.Sexually transmitted diseases among persons with HIV with low viral load.Revisiting the methodology of measuring HIV community viral load.Redefining Prevention and Care: A Status-Neutral Approach to HIV.Proposing a New Indicator for the National Human Immunodeficiency Virus/AIDS Strategy: Percentage of Newly Diagnosed Persons Achieving Viral Suppression Within 3 Months of DiagnosisReduction in Gaps in High CD4 Count and Viral Suppression Between Transgender and Cisgender Persons Living With HIV in New York City, 2007-2016Potential Misclassification of HIV-Positive Persons As Transgender MenUndiagnosed HIV and HCV Infection in a New York City Emergency Department, 2015Transition from paediatric to adult care among persons with perinatal HIV infection in New York City, 2006-2015USE OF MEDIAN AGE AT DEATH TO ASSESS HIV MORTALITYAn expanded HIV screening strategy in the Emergency Department fails to identify most patients with undiagnosed infection: insights from a blinded serosurvey
P50
Q28293358-53E7B99C-CD7A-4363-9B9A-BED9641126E8Q30725412-4F1CB76E-01D5-4507-9E0F-15DBE89C0652Q30843408-24FF12FD-F3E8-4026-B720-85EE6A2566E5Q30869487-6F262D28-9149-4DD4-8439-26D0BC718593Q35805633-98F4C995-3D0A-4ED8-B169-4597C4D84B47Q36614360-47191858-6C65-4586-AB4E-0FD4EA9404ACQ37075722-023D53A9-798E-4C94-8E06-CDF808B3FCA5Q37247568-173F6525-9134-4F8D-A202-6105E7FBB44FQ38782103-E59E37B8-BB41-403F-BED9-CA5D7AD70E73Q38819369-F666A73E-326A-426E-AE6A-7417A54A07FDQ38957635-95EF94D4-4772-4693-B048-352FE81B1222Q40056094-731016F7-431A-4A4C-A26F-097B128318E8Q40496694-A3D83142-411C-4004-A71C-DF5EE598421CQ40533926-2983666C-F5DC-4D49-86CD-4DB6556F3CC2Q40839876-2DA22CE9-A35E-429C-B358-342E64660D87Q41332527-3F52B127-7675-4343-9FEA-DA3B178FF8D2Q41543908-167BD7F8-05CD-466C-BA57-5BF5D339130FQ41602283-05326EE5-A88B-4B7F-956D-E92B98C6FB70Q41730117-7A2B0B58-0876-4654-AA0D-E913EFB1557AQ44313967-836C3EFC-DD36-45F1-8D21-EFEA9395F6BCQ45142355-6BF25AB1-89D7-43B3-BD81-AE7171A80C8CQ45366460-313A2A2B-D613-4C4E-A943-4C6B26A6E0EEQ45948609-BCAD627B-913C-474D-A773-18E3F2B76A3AQ46603072-8C7366F9-A881-4A8E-9310-00F4C20FA60CQ46617727-B40293BA-4806-4395-B908-70CCF74BBB1CQ46744351-68FD043D-9594-48D1-B95B-EE3FE0237974Q47555060-787AE378-9595-4521-AF04-D0E560F3E1A2Q47576944-7B447DA6-7288-4C6F-BDD9-3DE5D116E587Q47751367-4690FB22-38FF-4537-B715-A3F5F79F6C3EQ51835889-913E2977-DFE7-4A49-9988-B2E06BFD93A3Q51867281-C7D3833F-2989-47BA-9E8D-82F15FC32D96Q51874880-4B2B7310-ECE5-4639-888D-63CA86B80442Q55415446-D9CA7B8A-23B4-4C1C-BD03-CDA35E2E7048Q57284697-CA58D521-F10A-4C51-B460-4EB46B61B184Q64135363-09126665-7D08-4455-AE8F-49580858031FQ64137503-81C4D712-23F4-483F-AE5A-FE444DC054B5Q64138093-A7884595-B22E-4D0D-939D-976581EAF49AQ89077326-A236AB95-20BE-4F86-BB42-52A72DCAF173Q91982727-BD6AE792-2C76-4EF0-B71C-0DD015384D70Q92410435-0EA2BA5B-F419-4D45-B1CC-DE24CD8E9582
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Qiang Xia
@ast
Qiang Xia
@en
Qiang Xia
@es
Qiang Xia
@nl
Qiang Xia
@sl
type
label
Qiang Xia
@ast
Qiang Xia
@en
Qiang Xia
@es
Qiang Xia
@nl
Qiang Xia
@sl
prefLabel
Qiang Xia
@ast
Qiang Xia
@en
Qiang Xia
@es
Qiang Xia
@nl
Qiang Xia
@sl
P106
P1960
uWClZmEAAAAJ
P2456
P31
P496
0000-0002-2493-6001